SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-292706
Filing Date
2023-12-11
Accepted
2023-12-11 17:15:33
Documents
19
Period of Report
2023-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d634758d8k.htm   iXBRL 8-K 43630
2 EX-4.1 d634758dex41.htm EX-4.1 84090
3 EX-4.2 d634758dex42.htm EX-4.2 91456
4 EX-4.3 d634758dex43.htm EX-4.3 88309
5 EX-10.1 d634758dex101.htm EX-10.1 312208
6 EX-10.2 d634758dex102.htm EX-10.2 74899
7 EX-99.1 d634758dex991.htm EX-99.1 12259
11 GRAPHIC g634758g1212003126462.jpg GRAPHIC 2334
  Complete submission text file 0001193125-23-292706.txt   1000597

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA inab-20231211.xsd EX-101.SCH 2836
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20231211_lab.xml EX-101.LAB 18738
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20231211_pre.xml EX-101.PRE 11698
13 EXTRACTED XBRL INSTANCE DOCUMENT d634758d8k_htm.xml XML 3492
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 231478958
SIC: 2836 Biological Products, (No Diagnostic Substances)